Barclays analyst Tracy Benguigui downgrades Allstate (NYSE:ALL) from Overweight to Equal-Weight and lowers the price target from $147 to $123.
Barclays Downgrades Allstate to Equal-Weight, Lowers Price Target to $123
Barclays analyst Tracy Benguigui downgrades Allstate (NYSE:ALL) from Overweight to Equal-Weight and lowers the price target from $147 to $123.
Related Posts
BMO Capital Maintains Outperform on Horizon Therapeutics, Raises Price Target to $46
BMO Capital maintains Horizon Therapeutics (NASDAQ:HZNP) with a Outperform and raises the price target from $40 to $46.
Zoom Steams Up Videoconferencing Rivalry
Zoom Video Communications Inc (NASDAQ:ZM) has announced plans to expand its automatic live transcriptions with live translation and turn its whiteboard…
Meta Warned Workers To Shape Up: Now It’s Firing Them At Random Using An Algorithm
Meta Platforms Inc (NASDAQ: META), formerly known as Facebook, in June told its employees that it planned to not only reduce its hiring target, but it was going to "turn up the heat" on employees via stricter performance management with the intention of weeding out underperforming employees.